Andrew Reardon sold $1.4M of Ligand Pharmaceuticals Incorporated (LGND)

Executed Oct 2, disclosed Oct 6, 4 days later.

Value, as filed

$1.4M

4,748 sh across 4 lots

Executed

Oct 2

the trade date, as filed

Disclosed

Oct 6

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrew Reardon CLO & Secretary profile →

Andrew Reardon (CLO & Secretary) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $1.5M of LGND (4,796 sh across 6 lots, as filed), executed Jul 1.

The name

LGND

Ligand Pharmaceuticals Incorporated LGND · Healthcare · 37 filings in 24 months ticker →

Healthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew Reardon in LGND

LGNDSALE Ligand Pharmaceuticals Incorporated $1.3M
4,037 sh across 8 lots
Exec Nov 2
Filed Nov 4 · 4:23 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.3M
4,700 sh across 4 lots
Exec Sep 3
Filed Sep 8 · 6:34 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.3M
4,505 sh across 6 lots
Exec Aug 3
Filed Aug 4 · 6:42 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.5M
4,796 sh across 6 lots
Exec Jul 1
Filed Jul 6 · 5:11 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $999K
4,400 sh across 5 lots
Exec Jun 1
Filed Jun 2 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.0M
4,532 sh across 5 lots
Exec May 1
Filed May 4 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $846K
4,203 sh across 4 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $666K
3,200 sh across 3 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET